Qube Research & Technologies (QRT)
BDTX icon

Qube Research & Technologies (QRT)’s Black Diamond Therapeutics BDTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.6K Sell
13,407
-156,211
-92% -$372K ﹤0.01% 3243
2025
Q4 		$412K Buy
169,618
+91,352
+117% +$324K ﹤0.01% 2860
2025
Q3 		$297K Buy
78,266
+11,815
+18% +$34.6K ﹤0.01% 2852
2025
Q2 		$165K Buy
66,451
+40,703
+158% +$78.4K ﹤0.01% 2943
2025
Q1 		$39.9K Sell
25,748
-81,527
-76% -$171K ﹤0.01% 3150
2024
Q4 		$230K Buy
+107,275
New +$307K ﹤0.01% 2799
2024
Q3 		– Sell
-123,034
Closed -$573K – 3322
2024
Q2 		$573K Sell
123,034
-49,595
-29% -$266K ﹤0.01% 2103
2024
Q1 		$875K Buy
172,629
+125,919
+270% +$508K ﹤0.01% 2227
2023
Q4 		$131K Buy
46,710
+43,792
+1,501% +$103K ﹤0.01% 2996
2023
Q3 		$8.38K Sell
2,918
-19,986
-87% -$73.6K ﹤0.01% 3355
2023
Q2 		$116K Buy
+22,904
New +$46.8K ﹤0.01% 1923
2022
Q4 		– Sell
-18,813
Closed -$32K – 2467
2022
Q3 		$32K Sell
18,813
-1,199
-6% -$3.7K ﹤0.01% 2218
2022
Q2 		$49K Buy
+20,012
New +$46.5K ﹤0.01% 2129
2021
Q3 		– Sell
-20,189
Closed -$246K – 2210
2021
Q2 		$246K Buy
+20,189
New +$399K ﹤0.01% 1693

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BDTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Black Diamond Therapeutics (BDTX) stake by 92% in Q1 2026, selling an estimated $372K and leaving 13,407 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Qube Research & Technologies (QRT) first reported a position in BDTX in Q2 2021 and has held it in 14 quarters since. The position peaked at $875K in Q1 2024. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 13,407 shares of Black Diamond Therapeutics worth $28.6K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 156,211 Black Diamond Therapeutics shares in Q1 2026, an estimated $372K.
  • Black Diamond Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3243 holding.
  • Qube Research & Technologies (QRT) first reported a position in Black Diamond Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • Qube Research & Technologies (QRT)'s Black Diamond Therapeutics position peaked at $875K in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.